GlyTech

GlyTech develops glycan-focused technologies to create novel pharmaceuticals and support drug discovery for both domestic and international partners. The company provides contract research services, active pharmaceutical ingredient (API) sales, and reagent sales, leveraging proprietary glycan-related technology across multiple therapeutic modalities. Its customers include academic researchers and pharmaceutical companies seeking glycoengineering, analytical services, and production support for drug discovery and development.